MedTrace Logo

Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure

NCT04471610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2020-07-17

No results posted yet for this study

Summary

The goal of this study is to explore whether the availability of serial NT-proBNP measurements together with safety parameters such as electrolytes and creatinine may influence treatment decision in patients with acute decompensated heart failure (ADHF) leading to more rapid and faster dose increase of prognostic therapies and earlier hospital discharge.

Conditions

  • Acute Decompensated Heart Failure

Interventions

OTHER

Serial measurements of NT-pro BNP, potassium, sodium, and creatinine every second business day

Serial measurements of NT-proBNP, sodium, potassium, and creatinine in the NT-proBNP-group vs. no serial measurements in control group. In the intervention group the body weight, vital parameters, therapy changes and adverse events are documented the above mention serial measurement every second business day.

Sponsors & Collaborators

  • Prof. Dr. Jörg Leuppi

    lead OTHER

Principal Investigators

  • Jörg D. Leuppi, Prof. · Head of Medical University Clinic, Cantonal hospital Baselland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-23
Primary Completion
2020-05-20
Completion
2020-05-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471610 on ClinicalTrials.gov